Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794976 · ClinicalTrials.gov registry record · Phase 2
Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis
A Phase 2 study of Lateral Epicondylitis and Tennis Elbow, sponsored by Travanti Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 216
- Enrollment target
- 10
- Study locations
NCT00794976 is a Phase 2 study of Lateral Epicondylitis and Tennis Elbow that has completed, run by Travanti Pharma. The registered enrollment target is 216 participants, above the 97-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (123% higher). The trial reports 10 study locations across 9 states.
The verdict
NCT00794976, a Phase 2 study of Lateral Epicondylitis and Tennis Elbow, has completed, sponsored by Travanti Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 216 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objective of this study is to determine the safety and efficacy of a dexamethasone iontophoretic transdermal patch for the treatment of pain associated with lateral epicondylitis (tennis elbow).
Conditions Studied
Interventions
- DRUG Placebo Patch
- DRUG Dexamethasone Iontophoretic Patch (low dose)
- DRUG Dexamethasone Iontophoretic Patch (high dose)
- DRUG Dexamethasone Passive Patch
Study Locations (10)
Arizona
- - Phoenix
- - Tucson
Alabama
- - Birmingham
California
- - San Diego
Colorado
- - Steamboat Springs
Florida
- - Tampa
Oklahoma
- - Oklahoma City
South Carolina
- - Columbia
Texas
- - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00794976
The ClinicalTrials.gov registry entry for NCT00794976 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 97-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (123% higher). The listed sponsor is Travanti Pharma, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lateral Epicondylitis appearing as the primary indexed condition, and to 4 interventions - of which Placebo Patch is the first listed.
NCT00794976 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Arizona, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT00794976 about?
NCT00794976 is a clinical study titled "Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis". The objective of this study is to determine the safety and efficacy of a dexamethasone iontophoretic transdermal patch for the treatment of pain associated with lateral epicondylitis (tennis elbow).
What is the current status of trial NCT00794976?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 216 participants. The study started on 2008-10. Estimated completion is 2009-05.
What conditions does trial NCT00794976 study?
This clinical trial studies the following conditions: Lateral Epicondylitis, Tennis Elbow.
What interventions are being tested in trial NCT00794976?
The interventions under investigation include: Placebo Patch (DRUG), Dexamethasone Iontophoretic Patch (low dose) (DRUG), Dexamethasone Iontophoretic Patch (high dose) (DRUG), Dexamethasone Passive Patch (DRUG).
Who is sponsoring clinical trial NCT00794976?
This trial is sponsored by Travanti Pharma, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00794976 being conducted?
This trial has 10 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lateral Epicondylitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis
COMPLETED · Phase 2
-
Blood Flow Restriction & Tennis Elbow Rehab
RECRUITING · NA
-
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
RECRUITING · Phase 4
-
Trial of Blood Flow Restriction Plus Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis
ACTIVE NOT RECRUITING · NA
-
Doxycycline for Elbow Tendinopathy
ACTIVE NOT RECRUITING · Phase 1
-
Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.